Novo Nordisk

back to list >>

The BAM Group’s role with Novo Nordisk, the first company to produce insulin, is to support the Training and Leadership Providers with informational booths endorsing their services. The exhibits—both product-based and human resource-based—are used for Plan of Action and Speaker Training meetings, aiding Novo Nordisk in its commitment to prevent, treat, and ultimately cure diabetes.